3 October, 2021 by The TZ Newswire Staff Comments Off on Active Biotech: Tasquinimod clinical development in multiple myeloma advances into combination therapy following completion of the initial phase of the ongoing trial in the US
Active Biotech: Tasquinimod clinical development in multiple myeloma advances into combination therapy following completion of the initial phase of the ongoing trial in the US
Lund Sweden, October 3, 2021 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that the ongoing trial of tasquinimod in multiple myeloma has reached an important milestone. Ten patients have been treated with increasing doses of tasquinimod, which was generally well tolerated. The optimal dose and schedule of tasquinimod, when used as a single agent in patients with multiple myeloma has been established at 1 mg per day after a one-week run in of 0.5 mg daily. This is similar to the treatment schedule used in previous studies of tasquinimod.
3 October, 2021 by The TZ Newswire Staff Comments Off on Money in 2030: A future where DeFi and CBDCs can work together
Money in 2030: A future where DeFi and CBDCs can work together
In coexistence with mutual benefits, decentralized finance and central bank digital currencies will finally make money universally available worldwide.
3 October, 2021 by The TZ Newswire Staff Comments Off on XRP, Finalto Sale, Bitcoin Whale Activity, Refinitiv US Fine: Editor’s Pick
XRP, Finalto Sale, Bitcoin Whale Activity, Refinitiv US Fine: Editor’s Pick
ICYMI: the biggest news stories of the week
3 October, 2021 by The TZ Newswire Staff Comments Off on Can Teladoc Keep Its Competitive Advantage?
Can Teladoc Keep Its Competitive Advantage?
Teladoc Health (NYSE: TDOC) is no doubt the leader in the telehealth space today. But as customers and employers see the increased popularity of telehealth services, can Teladoc maintain its spot on top?
In this video from “Beat & Raise” on Motley Fool Live, recorded on Sept. 23, Fool.com contributors Brian Withers and Taylor Carmichael discuss some of Teladoc’s biggest competitors, and some things investors should keep their eyes on.
3 October, 2021 by The TZ Newswire Staff Comments Off on 3 Dividend-Paying Tech Stocks to Buy in October
3 Dividend-Paying Tech Stocks to Buy in October
The common narrative around technology is usually one of growth. However, there are quite a few mature dividend stocks out there, whose payouts should also grow handsomely along with revolutions in cloud computing, artificial intelligence, 5G, and the Internet of Things.
With many tech stocks having sold off recently on fears of higher interest rates, the following three stocks all look like solid buys on the recent dip. And while their current yields may not turn many heads, those yields should grow handsomely in the years to come as those tech trends take off.
3 October, 2021 by The TZ Newswire Staff Comments Off on Got $1,000? 3 Solid Investments to Help You Grow Wealth
Got $1,000? 3 Solid Investments to Help You Grow Wealth
You’ll often hear that it takes money to make money. But let’s face it — money can sometimes be in short supply. And if you only have limited funds to work with, you’ll need to invest your cash wisely. If you’re sitting on $1,000 only, here are three great investments to think about adding to your portfolio.
The great thing about exchange-traded funds, or ETFs, is that they don’t require a ton of research. Plus, they’re an efficient way to build a portfolio that’s more diverse.
3 October, 2021 by The TZ Newswire Staff Comments Off on 3 Growth Stocks That Could Produce Monster Returns
3 Growth Stocks That Could Produce Monster Returns
Cord-cutting accelerated during the pandemic, as a record number of U.S. households cancelled cable and satellite services, according to eMarketer. However, there are still more households with pay TV than households that have never had pay TV, meaning the shift toward streaming entertainment could be far from over.
At the same time, linear TV ad spend is expected to exceed $67 billion in the U.S. in 2021, while connected TV ad spend will total just $13 billion. Again, these statistics suggest that we are still in the early days of streaming adoption.